 | Up a level |
James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman, Robin; Alzouebi, Mymoona; Beesley, Sharon; Birtle, Alison J; ... (2016). Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet, 387(10024), pp. 1163-1177. Elsevier 10.1016/S0140-6736(15)01037-5
Pasquier, David; Barney, Brandon; Sundar, Santhanam; Poortmans, Philip; Villa, Salvador; Nasrallah, Haitam; Boujelbene, Noureddine; Ghadjar, Pirus; Lassen-Ramshad, Yasmin; Senkus, Elżbieta; Oar, Andrew; Roelandts, Martine; Amichetti, Maurizio; Vees, Hansjoerg; Zilli, Thomas; Ozsahin, Mahmut (2015). Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients. International journal of radiation oncology, biology, physics, 92(4), pp. 904-910. Elsevier 10.1016/j.ijrobp.2015.03.019
Sternberg, Cora N; Skoneczna, Iwona; Kerst, J Martijn; Albers, Peter; Fossa, Sophie D; Agerbaek, Mads; Dumez, Herlinde; de Santis, Maria; Théodore, Christine; Leahy, Michael G; Chester, John D; Verbaeys, Antony; Daugaard, Gedske; Wood, Lori; Witjes, J Alfred; de Wit, Ronald; Geoffrois, Lionel; Sengelov, Lisa; Thalmann, George; Charpentier, Danielle; ... (2015). Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial. The lancet oncology, 16(1), pp. 76-86. Elsevier 10.1016/S1470-2045(14)71160-X
